| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Regular Articles |
From the Department of Cardiovascular Research, Genentech Inc., South San Francisco, California
Various in vitro models have been described that emulate one or more of the processes involved in angiogenesis in vivo. In the present study endothelial cells were cultured in three-dimensional type I collagen lattices in the presence of a mixture of basic fibroblast growth factor, vascular endothelial cell growth factor, and phorbol myristate acetate. Under these conditions, the endothelial cells rapidly assemble into an interconnected network of tube-like structures with a high frequency of intercellular canals or lumens. The formation of the networks and lumens was completely blocked by cycloheximide and by actinomycin D. Monoclonal antibodies directed against CD31 or vascular endothelial cadherin (VE-cadherin) inhibited the formation of endothelial tubes. A subtle difference in the morphology of cells treated with anti-CD31 versus anti-VE-cadherin was noted; namely, cells incubated in the presence of CD31 antibodies were rounded or formed attenuated tube-like structures, both of which were characterized by a single, large intra- or intercellular vacuole. In contrast, tube formation by cells incubated in the presence of VE-cadherin antibodies was also impaired and, most notably, demonstrated a reduction in either vacuole formation or vacuole fusion, depending upon the monoclonal antibody used. We suggest that the two endothelial-junction-associated proteins, CD31 and VE-cadherin, play different roles in the process of tube formation. CD31 appears to be required for cell elongation, migration, and/or invasion in the gels as well as for cell-cell association to form the network structures. VE-cadherin also appears to be required for cell-cell association, but additionally appears to play some role in the process of vacuolization or vacuole fusion leading to intercellular lumen formation.
This article has been cited by other articles:
![]() |
D. Navaratna, J. Maestas, P. G. McGuire, and A. Das Suppression of Retinal Neovascularization With an Antagonist to Vascular Endothelial Cadherin Arch Ophthalmol, August 1, 2008; 126(8): 1082 - 1088. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Liu, D. J. Cao, I. M. Sainz, Y.-L. Guo, and R. W. Colman The inhibitory effect of HKa in endothelial cell tube formation is mediated by disrupting the uPA-uPAR complex and inhibiting its signaling and internalization Am J Physiol Cell Physiol, July 1, 2008; 295(1): C257 - C267. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Koh, R. D. Mahan, and G. E. Davis Cdc42- and Rac1-mediated endothelial lumen formation requires Pak2, Pak4 and Par3, and PKC-dependent signaling J. Cell Sci., April 1, 2008; 121(7): 989 - 1001. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. C. Prozialeck, J. R. Edwards, D. W. Nebert, J. M. Woods, A. Barchowsky, and W. D. Atchison The Vascular System as a Target of Metal Toxicity Toxicol. Sci., April 1, 2008; 102(2): 207 - 218. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. H. Chidlow Jr., D. Shukla, M. B. Grisham, and C. G. Kevil Pathogenic angiogenesis in IBD and experimental colitis: new ideas and therapeutic avenues Am J Physiol Gastrointest Liver Physiol, July 1, 2007; 293(1): G5 - G18. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Deleuze, E. Chalhoub, R. El-Hajj, C. Dohet, M. Le Clech, P.-O. Couraud, P. Huber, and D. Mathieu TAL-1/SCL and Its Partners E47 and LMO2 Up-Regulate VE-Cadherin Expression in Endothelial Cells Mol. Cell. Biol., April 1, 2007; 27(7): 2687 - 2697. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. C. Boquest, A. Noer, A. L. Sorensen, K. Vekterud, and P. Collas CpG Methylation Profiles of Endothelial Cell-Specific Gene Promoter Regions in Adipose Tissue Stem Cells Suggest Limited Differentiation Potential Toward the Endothelial Cell Lineage Stem Cells, April 1, 2007; 25(4): 852 - 861. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. M. Borthwick, A. S. Johnson, M. Partington, J. Burn, R. Wilson, and H. M. Arthur Therapeutic levels of aspirin and salicylate directly inhibit a model of angiogenesis through a Cox-independent mechanism FASEB J, October 1, 2006; 20(12): 2009 - 2016. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. J. Byfield, S. Tikku, G. H. Rothblat, K. J. Gooch, and I. Levitan OxLDL increases endothelial stiffness, force generation, and network formation J. Lipid Res., April 1, 2006; 47(4): 715 - 723. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. E. Davis and D. R. Senger Endothelial Extracellular Matrix: Biosynthesis, Remodeling, and Functions During Vascular Morphogenesis and Neovessel Stabilization Circ. Res., November 25, 2005; 97(11): 1093 - 1107. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. M. Muller, B. B. Singer, E. Klaile, B. Obrink, and L. Lucka Transmembrane CEACAM1 affects integrin-dependent signaling and regulates extracellular matrix protein-specific morphology and migration of endothelial cells Blood, May 15, 2005; 105(10): 3925 - 3934. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Sengupta, S. Caballero, R. N. Mames, A. M. Timmers, D. Saban, and M. B. Grant Preventing Stem Cell Incorporation into Choroidal Neovascularization by Targeting Homing and Attachment Factors Invest. Ophthalmol. Vis. Sci., January 1, 2005; 46(1): 343 - 348. [Abstract] [Full Text] [PDF] |
||||
![]() |
T.-S. Li, H. Ito, M. Hayashi, A. Furutani, M. Matsuzaki, and K. Hamano Cellular expression of integrin-{beta}1 is of critical importance for inducing therapeutic angiogenesis by cell implantation Cardiovasc Res, January 1, 2005; 65(1): 64 - 72. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. D. O'Brien, G. Cao, A. Makrigiannakis, and H. M. DeLisser Role of immunoreceptor tyrosine-based inhibitory motifs of PECAM-1 in PECAM-1-dependent cell migration Am J Physiol Cell Physiol, October 1, 2004; 287(4): C1103 - C1113. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Zhou, A. Stuart, L. E. Dettin, G. Rodriguez, B. Hoel, and G. I. Gallicano Desmoplakin is required for microvascular tube formation in culture J. Cell Sci., July 1, 2004; 117(15): 3129 - 3140. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Furusawa, K. Ohkoshi, C. Honda, S. Takahashi, and T. Tokunaga Embryonic Stem Cells Expressing Both Platelet Endothelial Cell Adhesion Molecule-1 and Stage-Specific Embryonic Antigen-1 Differentiate Predominantly into Epiblast Cells in a Chimeric Embryo Biol Reprod, May 1, 2004; 70(5): 1452 - 1457. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Yamamoto, T. Takahashi, T. Asahara, N. Ohura, T. Sokabe, A. Kamiya, and J. Ando Proliferation, differentiation, and tube formation by endothelial progenitor cells in response to shear stress J Appl Physiol, November 1, 2003; 95(5): 2081 - 2088. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Merkulova-Rainon, P. England, S. Ding, C. Demerens, and G. Tobelem The N-terminal Domain of Hepatocyte Growth Factor Inhibits the Angiogenic Behavior of Endothelial Cells Independently from Binding to the c-met Receptor J. Biol. Chem., September 26, 2003; 278(39): 37400 - 37408. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Salcedo, X. Zhang, H. A. Young, N. Michael, K. Wasserman, W.-H. Ma, M. Martins-Green, W. J. Murphy, and J. J. Oppenheim Angiogenic effects of prostaglandin E2 are mediated by up-regulation of CXCR4 on human microvascular endothelial cells Blood, September 15, 2003; 102(6): 1966 - 1977. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Ishida, R. K. Kundu, E. Yang, K.-i. Hirata, Y.-D. Ho, and T. Quertermous Targeted Disruption of Endothelial Cell-selective Adhesion Molecule Inhibits Angiogenic Processes in Vitro and in Vivo J. Biol. Chem., September 5, 2003; 278(36): 34598 - 34604. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Gu, J. Zhang, D. W. Brann, and F.-S. X. Yu Brain and Retinal Vascular Endothelial Cells with Extended Life Span Established by Ectopic Expression of Telomerase Invest. Ophthalmol. Vis. Sci., July 1, 2003; 44(7): 3219 - 3225. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Ding, T. Merkulova-Rainon, Z. C. Han, and G. Tobelem HGF receptor up-regulation contributes to the angiogenic phenotype of human endothelial cells and promotes angiogenesis in vitro Blood, June 15, 2003; 101(12): 4816 - 4822. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. V. SOMLYO, C. PHELPS, C. DIPIERRO, M. ETO, P. READ, M. BARRETT, J. J. GIBSON, M. C. BURNITZ, C. MYERS, and A. P. SOMLYO Rho kinase and matrix metalloproteinase inhibitors cooperate to inhibit angiogenesis and growth of human prostate cancer xenotransplants FASEB J, February 1, 2003; 17(2): 223 - 234. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Venkiteswaran, K. Xiao, S. Summers, C. C. Calkins, P. A. Vincent, K. Pumiglia, and A. P. Kowalczyk Regulation of endothelial barrier function and growth by VE-cadherin, plakoglobin, and beta -catenin Am J Physiol Cell Physiol, September 1, 2002; 283(3): C811 - C821. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. E. Gerritsen, R. Soriano, S. Yang, G. Ingle, C. Zlot, K. Toy, J. Winer, A. Draksharapu, F. Peale, T. D. Wu, et al. In silico data filtering to identify new angiogenesis targets from a large in vitro gene profiling data set Physiol Genomics, July 12, 2002; 10(1): 13 - 20. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. B. Kiosses, J. Hood, S. Yang, M. E. Gerritsen, D. A. Cheresh, N. Alderson, and M. A. Schwartz A Dominant-Negative p65 PAK Peptide Inhibits Angiogenesis Circ. Res., April 5, 2002; 90(6): 697 - 702. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. J. Bayless and G. E. Davis The Cdc42 and Rac1 GTPases are required for capillary lumen formation in three-dimensional extracellular matrices J. Cell Sci., March 15, 2002; 115(6): 1123 - 1136. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Wiewrodt, A. P. Thomas, L. Cipelletti, M. Christofidou-Solomidou, D. A. Weitz, S. I. Feinstein, D. Schaffer, S. M. Albelda, M. Koval, and V. R. Muzykantov Size-dependent intracellular immunotargeting of therapeutic cargoes into endothelial cells Blood, February 1, 2002; 99(3): 912 - 922. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Lafleur, M. M. Handsley, V. Knauper, G. Murphy, and D. R. Edwards Endothelial tubulogenesis within fibrin gels specifically requires the activity of membrane-type-matrix metalloproteinases (MT-MMPs) J. Cell Sci., January 9, 2002; 115(17): 3427 - 3438. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Ren, L. H. Michael, M. L. Entman, and N. G. Frangogiannis Morphological Characteristics of the Microvasculature in Healing Myocardial Infarcts J. Histochem. Cytochem., January 1, 2002; 50(1): 71 - 80. [Abstract] [Full Text] |
||||
![]() |
S. Yang, X. Xin, C. Zlot, G. Ingle, G. Fuh, B. Li, B. Moffat, A. M. de Vos, and M. E. Gerritsen Vascular Endothelial Cell Growth Factor-Driven Endothelial Tube Formation Is Mediated by Vascular Endothelial Cell Growth Factor Receptor-2, a Kinase Insert Domain-Containing Receptor Arterioscler. Thromb. Vasc. Biol., December 1, 2001; 21(12): 1934 - 1940. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Xu, W.E.I. Li, G.Y. Huang, R. Meyer, T. Chen, Y. Luo, M.P. Thomas, G.L. Radice, and C.W. Lo Modulation of mouse neural crest cell motility by N-cadherin and connexin 43 gap junctions J. Cell Biol., July 9, 2001; 154(1): 217 - 230. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. RayChaudhury, M. Elkins, D. Kozien, and M. T. Nakada Regulation of PECAM-1 in Endothelial Cells during Cell Growth and Migration Experimental Biology and Medicine, July 1, 2001; 226(7): 686 - 691. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. C. Hendrix, E. A. Seftor, P. S. Meltzer, L. M. G. Gardner, A. R. Hess, D. A. Kirschmann, G. C. Schatteman, and R. E. B. Seftor Expression and functional significance of VE-cadherin in aggressive human melanoma cells: Role in vasculogenic mimicry PNAS, June 12, 2001; (2001) 131209798. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. K. Sood, E. A. Seftor, M. S. Fletcher, L. M. G. Gardner, P. M. Heidger, R. E. Buller, R. E. B. Seftor, and M. J. C. Hendrix Molecular Determinants of Ovarian Cancer Plasticity Am. J. Pathol., April 1, 2001; 158(4): 1279 - 1288. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Xin, S. Yang, G. Ingle, C. Zlot, L. Rangell, J. Kowalski, R. Schwall, N. Ferrara, and M. E. Gerritsen Hepatocyte Growth Factor Enhances Vascular Endothelial Growth Factor-Induced Angiogenesis in Vitro and in Vivo Am. J. Pathol., March 1, 2001; 158(3): 1111 - 1120. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. E. Bell, A. Mavila, R. Salazar, K. J. Bayless, S. Kanagala, S. A. Maxwell, and G. E. Davis Differential gene expression during capillary morphogenesis in 3D collagen matrices: regulated expression of genes involved in basement membrane matrix assembly, cell cycle progression, cellular differentiation and G-protein signaling J. Cell Sci., January 8, 2001; 114(15): 2755 - 2773. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Marszalek, T. Daa, K. Kashima, I. Nakayama, and S. Yokoyama Ultrastructural and Morphometric Studies Related to Expression of the Cell Adhesion Molecule PECAM-1/CD31 in Developing Rat Lung J. Histochem. Cytochem., September 1, 2000; 48(9): 1283 - 1290. [Abstract] [Full Text] |
||||
![]() |
J. Kahn, F. Mehraban, G. Ingle, X. Xin, J. E. Bryant, G. Vehar, J. Schoenfeld, C. J. Grimaldi, F. Peale, A. Draksharapu, et al. Gene Expression Profiling in an in Vitro Model of Angiogenesis Am. J. Pathol., June 1, 2000; 156(6): 1887 - 1900. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. J. Bayless, R. Salazar, and G. E. Davis RGD-Dependent Vacuolation and Lumen Formation Observed during Endothelial Cell Morphogenesis in Three-Dimensional Fibrin Matrices Involves the {alpha}v{beta}3 and {alpha}5{beta}1 Integrins Am. J. Pathol., May 1, 2000; 156(5): 1673 - 1683. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. C. Hendrix, E. A. Seftor, P. S. Meltzer, L. M. G. Gardner, A. R. Hess, D. A. Kirschmann, G. C. Schatteman, and R. E. B. Seftor Expression and functional significance of VE-cadherin in aggressive human melanoma cells: Role in vasculogenic mimicry PNAS, July 3, 2001; 98(14): 8018 - 8023. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Cao, C. D. O'Brien, Z. Zhou, S. M. Sanders, J. N. Greenbaum, A. Makrigiannakis, and H. M. DeLisser Involvement of human PECAM-1 in angiogenesis and in vitro endothelial cell migration Am J Physiol Cell Physiol, May 1, 2002; 282(5): C1181 - C1190. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. B. Kiosses, J. Hood, S. Yang, M. E. Gerritsen, D. A. Cheresh, N. Alderson, and M. A. Schwartz A Dominant-Negative p65 PAK Peptide Inhibits Angiogenesis Circ. Res., April 5, 2002; 90(6): 697 - 702. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |